130 related articles for article (PubMed ID: 10744362)
1. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group.
Krcméry V; Kovacicová G
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):7-11. PubMed ID: 10744362
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
Krcmery V; Huttova M; Mateicka F; Laho L; Jurga L; Ondrusova A; Tarekova Z; Kralinsky K; Hanzen J; Liskova A; Mrazova M; Sabo A; Pisarcikova M; Kovacicova G; Chovancova D; Szovenyiova Z
J Antimicrob Chemother; 2001 Oct; 48(4):521-5. PubMed ID: 11581231
[TBL] [Abstract][Full Text] [Related]
4. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
[TBL] [Abstract][Full Text] [Related]
5. Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
Bretagne S; Renaudat C; Desnos-Ollivier M; Sitbon K; Lortholary O; Dromer F;
J Antimicrob Chemother; 2017 Jun; 72(6):1784-1793. PubMed ID: 28333259
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Krcmery V; Mrazova M; Kunova A; Grey E; Mardiak J; Jurga L; Sabo A; Sufliarsky J; Sevcikova L; Sorkovska D; West D; Trupl J; Novotny J; Mateicka F
Support Care Cancer; 1999 Nov; 7(6):428-31. PubMed ID: 10541986
[TBL] [Abstract][Full Text] [Related]
7. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
8. Yeasts species distribution in Neonatal Intensive Care Units in northeast Argentina.
Giusiano GE; Mangiaterra M; Rojas F; Gómez V
Mycoses; 2004 Aug; 47(7):300-3. PubMed ID: 15310334
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients.
Kovacicová G; Spánik S; Kunová A; Trupl J; Sabo A; Koren P; Sulcová M; Mateicka F; Novotný J; Pichnová E; Jurga L; Chmelík B; Obertik T; West D; Krcéry V
Scand J Infect Dis; 2001; 33(5):367-74. PubMed ID: 11440223
[TBL] [Abstract][Full Text] [Related]
11. A first Portuguese epidemiological survey of fungaemia in a university hospital.
Costa-de-Oliveira S; Pina-Vaz C; Mendonça D; Gonçalves Rodrigues A
Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):365-74. PubMed ID: 18204871
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia.
Krcmery V; Laho L; Huttova M; Ondrusova A; Kralinsky K; Pevalova L; Dluholucky S; PISARCuÍKOVÁ M; Hanzen J; Filka J; Sejnová D; Lišková A; Purgelová A; Szovenyová Z; Koren P
J Med Microbiol; 2002 Feb; 51(2):110-116. PubMed ID: 11863261
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K
J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164
[TBL] [Abstract][Full Text] [Related]
15. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Małafiej E; Adamiec AC; Tworzyańska U
Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
[TBL] [Abstract][Full Text] [Related]
16. Trends in species causing fungaemia in a tertiary care medical centre over 12 years.
Malani PN; Bradley SF; Little RS; Kauffman CA
Mycoses; 2001 Dec; 44(11-12):446-9. PubMed ID: 11820256
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
[TBL] [Abstract][Full Text] [Related]
18. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals.
Nucci M; Colombo AL
Diagn Microbiol Infect Dis; 2007 May; 58(1):77-82. PubMed ID: 17368800
[TBL] [Abstract][Full Text] [Related]
19. Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis.
Kunova A; Trupl J; Demitrovicova A; Jesenska Z; Grausova S; Grey E; Pichna P; Kralovicova K; Sorkovska D; Krupova I; Spanik S; Studena M; Koren P; Krcmery V
Microb Drug Resist; 1997; 3(3):283-7. PubMed ID: 9271000
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of fungaemia at the University Hospital of the West Indies, Kingston, Jamaica.
Nicholson A; Rainford L
West Indian Med J; 2009 Dec; 58(6):580-4. PubMed ID: 20583687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
